JNJ
Price
$282.11
Change
+$5.89 (+2.13%)
Updated
Nov 9, 04:59 PM (EDT)
Capitalization
665.66B
77 days until earnings call
Intraday BUY SELL Signals
SNY
Price
$48.12
Change
+$1.08 (+2.30%)
Updated
Nov 9 closing price
Capitalization
112.71B
80 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

JNJ vs SNY

JNJ vs SNY Comparison Chart in %
View a ticker or compare two or three
VS
JNJ vs. SNY commentary
Nov 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNJ is a Buy and SNY is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for JNJ with price predictions
Nov 09, 2026

JNJ in upward trend: 10-day moving average broke above 50-day moving average on October 30, 2026

The 10-day moving average for JNJ crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 65%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where JNJ's RSI Oscillator exited the oversold zone, 17 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 59%.

The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on JNJ as a result. In 37 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 44%.

The Moving Average Convergence Divergence (MACD) for JNJ just turned positive on October 21, 2026. Looking at past instances where JNJ's MACD turned positive, the stock continued to rise in 21 of 47 cases over the following month. The odds of a continued upward trend are 45%.

JNJ moved above its 50-day moving average on October 26, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +3.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where JNJ advanced for three days, in 164 of 354 cases, the price rose further within the following month. The odds of a continued upward trend are 46%.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where JNJ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 43%.

JNJ broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for JNJ entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 2 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 19 (best 1 - 100 worst), indicating outstanding price growth. JNJ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.834) is normal, around the industry mean (-1.421). P/E Ratio (31.640) is within average values for comparable stocks, (21.700). Projected Growth (PEG Ratio) (2.852) is also within normal values, averaging (5.738). Dividend Yield (0.019) settles around the average of (0.038) among similar stocks. P/S Ratio (6.658) is also within normal values, averaging (4.033).

A.I.Advisor
a Summary for SNY with price predictions
Nov 09, 2026

SNY in upward trend: 10-day moving average broke above 50-day moving average on November 02, 2026

The 10-day moving average for SNY crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 65%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 16, 2026. You may want to consider a long position or call options on SNY as a result. In 56 of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.

The Moving Average Convergence Divergence (MACD) for SNY just turned positive on October 15, 2026. Looking at past instances where SNY's MACD turned positive, the stock continued to rise in 21 of 46 cases over the following month. The odds of a continued upward trend are 46%.

SNY moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +2.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where SNY advanced for three days, in 154 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 51%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.

SNY broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SNY entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. SNY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 63 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock slightly worse than average.

The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.629) is normal, around the industry mean (-1.421). P/E Ratio (28.596) is within average values for comparable stocks, (21.700). SNY's Projected Growth (PEG Ratio) (27.976) is very high in comparison to the industry average of (5.738). SNY's Dividend Yield (0.169) is considerably higher than the industry average of (0.038). P/S Ratio (1.829) is also within normal values, averaging (4.033).

FUNDAMENTALS RATINGS
JNJ vs SNY: Fundamental Ratings
JNJ
SNY
OUTLOOK RATING
1..100
3143
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
263
SMR RATING
1..100
3781
PRICE GROWTH RATING
1..100
1941
P/E GROWTH RATING
1..100
77
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JNJ's Valuation (76) in the Pharmaceuticals Major industry is in the same range as SNY (88). This means that JNJ’s stock grew similarly to SNY’s over the last 12 months.

JNJ's Profit vs Risk Rating (2) in the Pharmaceuticals Major industry is somewhat better than the same rating for SNY (63). This means that JNJ’s stock grew somewhat faster than SNY’s over the last 12 months.

JNJ's SMR Rating (37) in the Pharmaceuticals Major industry is somewhat better than the same rating for SNY (81). This means that JNJ’s stock grew somewhat faster than SNY’s over the last 12 months.

JNJ's Price Growth Rating (19) in the Pharmaceuticals Major industry is in the same range as SNY (41). This means that JNJ’s stock grew similarly to SNY’s over the last 12 months.

JNJ's P/E Growth Rating (7) in the Pharmaceuticals Major industry is in the same range as SNY (7). This means that JNJ’s stock grew similarly to SNY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
JNJSNY
RSI
ODDS (%)
Bullish Trend 4 days ago
59%
Bearish Trend 1 day ago
45%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
42%
Bearish Trend 1 day ago
47%
Momentum
ODDS (%)
Bullish Trend 1 day ago
44%
Bullish Trend 1 day ago
57%
MACD
ODDS (%)
Bullish Trend 1 day ago
45%
Bullish Trend 1 day ago
46%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
47%
Bullish Trend 1 day ago
53%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
50%
Bullish Trend 1 day ago
49%
Advances
ODDS (%)
Bullish Trend 1 day ago
46%
Bullish Trend 1 day ago
51%
Declines
ODDS (%)
Bearish Trend 7 days ago
43%
Bearish Trend 28 days ago
52%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
44%
Bearish Trend 1 day ago
50%
Aroon
ODDS (%)
Bearish Trend 1 day ago
41%
Bearish Trend 1 day ago
58%
COMPARISON
Comparison
Nov 10, 2026
Stock price -- (JNJ: $282.11 vs. SNY: $47.04)
Brand notoriety: JNJ: Notable vs. SNY: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: JNJ: 94% vs. SNY: 120%
Market capitalization -- JNJ: $665.66B vs. SNY: $112.71B
JNJ [@Pharmaceuticals: Major] is valued at $665.66B. SNY’s [@Pharmaceuticals: Major] market capitalization is $112.71B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $4.8K to $1.21T. The average market capitalization across the [@Pharmaceuticals: Major] industry is $215.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JNJ’s FA Score shows that 3 FA rating(s) are green while SNY’s FA Score has 1 green FA rating(s).

  • JNJ’s FA Score: 3 green, 2 red.
  • SNY’s FA Score: 1 green, 4 red.
According to our system of comparison, JNJ is a better buy in the long-term than SNY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JNJ’s TA Score shows that 6 TA indicator(s) are bullish while SNY’s TA Score has 5 bullish TA indicator(s).

  • JNJ’s TA Score: 6 bullish, 4 bearish.
  • SNY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, JNJ is a better buy in the short-term than SNY.

Price Growth

JNJ (@Pharmaceuticals: Major) experienced а +4.27% price change this week, while SNY (@Pharmaceuticals: Major) price change was +6.09% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.62%. For the same industry, the average monthly price growth was +1.66%, and the average quarterly price growth was +5.42%.

Reported Earning Dates

JNJ is expected to report earnings on Jan 26, 2027.

SNY is expected to report earnings on Jan 29, 2027.

Industries' Descriptions

@Pharmaceuticals: Major (+0.62% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

View a ticker or compare two or three
Interact to see
Advertisement

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with GSK. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
+2.13%
GSK - JNJ
53%
Loosely correlated
+2.40%
ABBV - JNJ
53%
Loosely correlated
+0.68%
NVS - JNJ
52%
Loosely correlated
+0.70%
MRK - JNJ
48%
Loosely correlated
+1.38%
AMGN - JNJ
47%
Loosely correlated
+1.04%
More

SNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNY has been loosely correlated with PFE. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SNY jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNY
1D Price
Change %
SNY100%
+2.30%
PFE - SNY
47%
Loosely correlated
-0.54%
JNJ - SNY
36%
Loosely correlated
+2.13%
MRK - SNY
35%
Loosely correlated
+1.38%
AMGN - SNY
35%
Loosely correlated
+1.04%
GILD - SNY
34%
Loosely correlated
+1.46%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MMED17.881.17
+7.00%
MiniMed Group Inc
EXYN2.300.06
+2.68%
Exyn Technologies Inc
EQBK49.370.66
+1.35%
Equity Bancshares
XEL80.170.50
+0.63%
Xcel Energy
CCAQ10.60N/A
N/A
Collective Acquisition Corp.